MDAI: the cash flow

MyFinsight

For the year ending 2025-12-31, MDAI had $10,237K increase in cash & cash equivalents over the period.

Cash Flow	2025-12-31
Net loss	-7,571
Depreciation expense	71
Amortization of debt issuance costs	454
Stock-based compensation	1,115
Amortization of right-of-use assets	564
Change in fair value of warrant liabilities	-3,249
Change in fair value of notes payable	220
Issuance of shares for borrowing related costs	-241
Transaction costs allocated to avenue warrants, investor warrants, and hudson warrants	704
Accounts receivable	-1,238
Inventory	413
Prepaid expenses	-761
Other assets	387
Accounts payable	-1,025
Accrued expenses	-869
Deferred revenue	-806
Lease liabilities	-528
Net cash used in operating activities	-9,920
Proceeds from issuance of common stock and warrants	10,638
Payment of issuance costs	642
Proceeds from notes payable	8,285
Payment of borrowing costs	47
Payments for notes payable	1,529
Proceeds from warrant exercises	2,526
Stock option exercises	889
Net cash provided by financing activities	20,120
Effect of exchange rate changes on cash	37
Net increase in cash	10,237
Cash, beginning of period	5,157
Cash, end of period	15,394

Unit: Thousand (K) dollars (except for numbers of shares and EPS).